{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:58:19Z","timestamp":1787986699598,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003358","name":"Gedeon Richter Plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003358","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.contraception.2025.111251","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:22:11Z","timestamp":1760030531000},"page":"111251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Risk of venous thromboembolism associated with chlormadinone acetate- and levonorgestrel-containing combined oral contraceptives \u2013 Insights from the retrospective RIVET-RCS study"],"prefix":"10.1016","volume":"153","author":[{"given":"Pauline","family":"De Corte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Klinghardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Bauerfeind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Boehnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.contraception.2025.111251_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.contraception.2010.01.011","article-title":"Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24\/4-day regimen","volume":"81","author":"Brucker","year":"2010","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2025.111251_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13625180701300194","article-title":"Combined hormonal contraception and venous thromboembolism","volume":"12","author":"Mart\u00ednez","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.111251_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2022.101016","article-title":"Oral contraceptives and stroke: foes or friends","volume":"67","author":"Reddy","year":"2022","journal-title":"Front Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.contraception.2025.111251_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40264-014-0149-8","article-title":"Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals","volume":"37","author":"Gourbil","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.contraception.2025.111251_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.contraception.2025.111251_bib6","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/j.thromres.2012.02.042","article-title":"Progestin-only contraception and venous thromboembolism","volume":"129","author":"Blanco-Molina","year":"2012","journal-title":"Thromb Res"},{"issue":"00","key":"10.1016\/j.contraception.2025.111251_bib7","first-page":"1","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data","author":"Schink","year":"2022","journal-title":"BJOG: Int J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.contraception.2025.111251_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2025.111251_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.contraception.2011.03.024","article-title":"The efficacy and safety of an oral contraceptive containing chlormadinone acetate: results of a pooled analysis of noninterventional trials in adult and adolescent women","volume":"84","author":"Schramm","year":"2011","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2025.111251_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2025.111251_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/AOG.0b013e3181b46f54","article-title":"Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives","volume":"114","author":"Cronin","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111251_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2288-9-77","article-title":"International active surveillance study of women taking oral contraceptives (INAS-OC Study)","volume":"9","author":"Dinger","year":"2009","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"10.1016\/j.contraception.2025.111251_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Final results of the INAS-SCORE study","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111251_bib14","unstructured":"Dinger Jand Barnett C. INternational Active Surveillance Study \u2013 Folate and Oral Contraceptives Utilization Study (INAS-FOCUS): INAS-FOCUS final study report. ENCePP."},{"issue":"5","key":"10.1016\/j.contraception.2025.111251_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the european active surveillance study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2025.111251_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/13625187.2021.1987410","article-title":"Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5 mg) and 17\u03b2-oestradiol (1.5 mg) (PRO-E2 study): risk of venous and arterial thromboembolism","volume":"26","author":"Reed","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.111251_bib17","unstructured":"SAS Institute Inc., Cary, North Carolina, USA. The SAS system for Windows. SAS."},{"issue":"20","key":"10.1016\/j.contraception.2025.111251_bib18","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2025.111251_bib19","unstructured":"De Corte Pand Heinemann K. Retrospective Cohort Study on the Risk of Venous Thromboembolism with the use of combined oral contraceptives containing Chlormadinone Acetate\/Ethinylestradiol and Levonorgestrel\/Ethinylestradiol. [July 03, 2023]; Available from: \u3008https:\/\/www.encepp.eu\/encepp\/viewResource.htm?id=46024\u3009."},{"key":"10.1016\/j.contraception.2025.111251_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.contraception.2025.111251_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"issue":"7","key":"10.1016\/j.contraception.2025.111251_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.aje.a115939","article-title":"What is a cause and how do we know one? A grammar for pragmatic epidemiology","volume":"133","author":"Susser","year":"1991","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.contraception.2025.111251_bib23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/ije\/17.4.955","article-title":"A strengthening programme for weak associations","volume":"17","author":"Rothman","year":"1988","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1016\/j.contraception.2025.111251_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/oxfordjournals.aje.a010135","article-title":"Bias in the evaluation of low-magnitude associations: an empirical perspective","volume":"151","author":"Shapiro","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.contraception.2025.111251_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/tera.1420460110","article-title":"Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogens","volume":"46","author":"Khoury","year":"1992","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.contraception.2025.111251_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1783\/147118908784734873","article-title":"Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy part 2. Principles of causality in epidemiological research: confounding, effect modification and strength of association","volume":"34","author":"Shapiro","year":"2008","journal-title":"J Fam Plan Reprod Health Care"},{"issue":"4","key":"10.1016\/j.contraception.2025.111251_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1783\/147118908786000596","volume":"34","author":"Shapiro","year":"2008","journal-title":"J Fam Plan Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.111251_bib28","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"issue":"5221","key":"10.1016\/j.contraception.2025.111251_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1126\/science.7618077","article-title":"Epidemiology faces its limits","volume":"269","author":"Taubes","year":"1995","journal-title":"Science"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425004421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425004421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:40:45Z","timestamp":1780548045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425004421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"alternative-id":["S0010782425004421"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111251","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of venous thromboembolism associated with chlormadinone acetate- and levonorgestrel-containing combined oral contraceptives \u2013 Insights from the retrospective RIVET-RCS study","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111251"}}